2-(4-Bromophenoxy)-5-chloropyridine

Catalog No.: 
ACKQMP044
CAS No.: 
1016769-83-7
Molecular Formula: 
C11H7BrClNO
Molecular Weight: 
284.54
2-(4-Bromophenoxy)-5-chloropyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$118.00InquiryInquiry
100mg95%$165.00InquiryInquiry
250mg95%$228.00InquiryInquiry
1g95%$555.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-Bromophenoxy)-5-chloropyridine
IUPAC Name2-(4-bromophenoxy)-5-chloropyridine
MDL No.MFCD09935149
Molecular FormulaC11H7BrClNO
Molecular Weight284.54
SMILESClC1=CN=C(OC2=CC=C(Br)C=C2)C=C1
InChI KeyVPPLHBKBUFSNBY-UHFFFAOYSA-N
Synonym2-(4-bromophenoxy)-5-chloropyridine
CAS No.1016769-83-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACKQMP044 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNYFL503 route compound structure diagram
    ACNYFL50316110-09-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKQMP044 route product structure diagram
    ACKQMP0441016769-83-7
Inquiry

2. ACKQMP044 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMOZX619 route compound structure diagram
    ACMOZX61940473-01-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKQMP044 route product structure diagram
    ACKQMP0441016769-83-7
Inquiry

3. ACKQMP044 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKQMP044 route product structure diagram
    ACKQMP0441016769-83-7
Inquiry

Comments (0)